| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $16.74M | - | |
| Other | 193.8K | $3.90M | - | |
| VP | 156.1K | $3.14M | - | |
| VP | 130.1K | $2.62M | - | |
| VP | 71.8K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Horton Amy48 | VP, Chief Accounting Officer | Sell | 4,329 | $29.66 | $128,398.14 | -3.1% | -16.7% | +50.3% | |
| Dec 4, 2024 | Green Andrew M | VP Regulatory | Sell | 7,618 | $30.00 | $228,540.00 | -18.5% | -15.4% | +53.2% | |
| Oct 1, 2024 | Horton Amy48 | VP, Chief Accounting Officer | Sale+OE | 12,430 | $26.18 | $325,414.91 | -8.2% | +8.8% | +56.5% | |
| Aug 26, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 3,167 | $26.55 | $84,095.88 | -1.9% | +7.1% | +66.0% | |
| Aug 16, 2024 | Getz Matthew A | VP, Human Resources | Sell | 9,420 | $25.31 | $238,434.33 | -11.7% | +7.8% | +71.0% | |
| Aug 15, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 2,383 | $25.76 | $61,392.99 | -1.4% | +7.8% | +69.6% | |
| Aug 13, 2024 | Semedo Anthony B.50 | Director | Sell | 9,709 | $24.99 | $242,627.91 | -22.1% | +15.1% | +74.4% | |
| May 10, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 1,250 | $23.42 | $29,275.13 | -0.7% | +7.6% | +22.9% | |
| May 9, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 979 | $23.79 | $23,285.52 | -0.6% | +7.5% | +23.5% | |
| Mar 20, 2024 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 2,183 | $20.39 | $44,511.37 | -2.6% | +12.0% | +16.9% |